NewLink Genetics Corp (NASDAQ:NLNK)

43.15
Delayed Data
As of May 29
 +0.26 / +0.61%
Today’s Change
17.32
Today|||52-Week Range
58.73
+8.55%
Year-to-Date
No recent news for NewLink Genetics Corp.

Today’s Trading

Previous close42.89
Today’s open42.75
Day’s range42.51 - 44.67
Volume674,202
Average volume (3 months)704,260
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-151.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+15,690.67%
P/E ratio11.2
Price/Sales6.41
Price/Book5.89

Competitors

 Today’s
change
Today’s
% change
EBSEmergent BioSolution...+0.11+0.35%
ZIOPZIOPHARM Oncology In...+0.06+0.64%
FOLDAmicus Therapeutics ...+0.12+0.98%
TXMDTherapeuticsMD Inc+0.35+5.20%
Data as of 4:05pm ET, 05/29/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$172.6M
Annual profit (last year)$102.9M
Net profit margin59.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers